Publicacions en revistes

• The link between resting-state functional connectivity and cognition in MS patients

  Álvaro J. Cruz Gómez, Noelia Ventura Campos, Antonio Belenguer Benavides, César Carlos Ávila Rivera, Cristina Forn Frías. MULTIPLE SCLEROSIS JOURNAL. Num. 3. Vol. 20. pp. 338-348. 2024. Científic.

• Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

  José E. Meca-Lallana, José M. Prieto González, Ana B. Caminero Rodríguez, Javier Olascoaga Urtaza, Ana M. Alonso, Eduardo Durán Ferreras, Raúl Espinosa, Julio Dotor, Mercedes Romera, Adrián Ares Luque, Domingo Pérez Ruiz, Carmen Calles, Miguel A. Hernández, Miguel Hervás García, Amelia Mendoza Rodríguez, Yasmina Berdei Montero, Nieves Téllez, Nicolás Herrera Varó, Javier Sotoca, Silvia Presas Rodríguez, Luis A. Querol Gutierrez, Mariona Hervás Pujol, Jordi Batlle Nadal, Gisela Martín Ozaeta, Laura Gubieras Lillo, Sergio Martínez Yélamos, Lluís Ramió Torrentá, Javier Mallada Frechin, Antonio Belenguer Benavides, Francisco Gascón Giménez, Bonaventura Casanova, Lamberto Landete Pascual, Leticia Berenguer, Laura Navarro, Montserrat Gómez Gutierrez, Carmen Durán, Ana Rodríguez Regal, Elena Álvarez, Daniel A. García Estévez, Ana M.º López Real, Miguel A. Llaneza González, María E. Marzo Sola, José L. Sánchez Menoyo, Agustín Oterino, Ramón Villaverde González, Tamara Castillo Triviño, Amaya Álvarez de Arcaya, Cristina Llarena. Neurology and Therapy. Vol. 12. pp. 2177-2193. 2023. Científic.

• Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study

  Carmen Alcalá, Carlos Quintanilla Bordás, Francisco Gascón, Ángel Pérez Sempere, Laura Navarro, María Carcelén Gadea, Lamberto Landete, Javier Mallada, Emmanuel Cañizares, Antonio Belenguer Benavides, Sara Carratalá, José Andrés Domínguez, Francisco Carlos Pérez Miralles, Sara Gil Perotín, Raquel Gasqué, Laura Cubas, Jessica Castillo, Bonaventura Casanova. JOURNAL OF NEUROLOGY . Num. 7. Vol. 269. pp. 3676-3681. 2022. Científic.

• Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain

  Lamberto Landeta, Francisco Pérez Miralles, Sara García, Antonio Belenguer Benavides, Francisco Gascón, José Andrés Domínguez, María Carcelén Gadea, Carlos Quintanilla Bordás, Laura Navarro, Laura Gabaldón, Bonaventura Casanova. FRONTIERS IN NEUROLOGY. Vol. 12. pp. 1-12. 2021. Científic.

• New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab

  Inmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez Lafuente, Rafael Arroyo, Harald Hegen, Florian Deisenhammer, Susana Sainz de la Maza, José C. Alvarez Cermeño, Guillermo Izquierdo, Dolores Paramo, Pedro Oliva, Bonaventura Casanova, Eduardo Agüera Morales, Diego Franciotta, Matteo Gastaldi, Oscar Fernández, Patricia Urbaneja, José M. García Domínguez, Fernando Romero, Alicia Laroni, ....... ......., Antonio Belenguer Benavides, ....... ......., Luisa M. Villar. FRONTIERS IN NEUROLOGY. Vol. 11. pp. 1-11. 2020. Científic.

• Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study

  Juan Manuel Sepúlveda Sánchez, Antonio Conde Moreno, Manuel Barón, Javier Pardo, Gaspar Reynés, Antonio Belenguer Benavides. Oncology Letters. Num. 6. Vol. 13. pp. 4093-4100. 2017. Científic.

• Hippocampal dysfunction is associated with memory impairment in multiple sclerosis: A volumetric and functional connectivity study

  Julio Alberto González Torre, Alvaro Javier Cruz Gómez, Antonio Belenguer Benavides, Carla Sanchis Segura, César Carlos Ávila Rivera, Cristina Forn Frias. MULTIPLE SCLEROSIS JOURNAL. Num. 14. Vol. 23. pp. 1854-1863. 2017. Científic.

• Exploring Neural Efficiency in Multiple Sclerosis Patients during the Symbol Digit Modalities Test: A Functional Magnetic Resonance Imaging Study

  María Sol Fittipaldi-Márquez, Álvaro Javier Cruz Gómez, Carla Sanchis Segura, Antonio Belenguer Benavides, César Carlos Ávila Rivera, Cristina Forn Frias. NEURODEGENERATIVE DISEASES . Num. 4-5. Vol. 17. pp. 199-207. 2017. Científic.

• Long-Term Adherence to IFN Beta-1α Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis

  O. Fernández, R. Arroyo, S. Martínez Yélamos, M. Marco, J.A. García Merino, D. Muñoz, E. Merino, A. Roque, RELOAD STUDY GROUP, Antonio Belenguer Benavides. PLOS ONE. Num. 8. Vol. 22. pp. 1-12. 2016. Científic.

• Increased regional gray matter atrophy and enhanced functional connectivy in male multiple sclerosis patients

  Carla Sanchis Segura, A.J. Cruz-Gómez, Antonio Belenguer Benavides, M.S. Fittipaldi, César Carlos Ávila Rivera, Cristina Forn Frias. NEUROSCIENCE LETTERS. Vol. 630. pp. 154-157. 2016. Científic.

• Cambios estructurales y funcionales del hipocampo en pacientes con esclerosis múltiple y su relación con procesos de memoria

  Álvaro Javier Cruz Gómez, Antonio Belenguer Benavides, Beatriz Martinez Bronchal, M. Sol Fittipaldi Marquez, Cristina Forn Frias. REVISTA DE NEUROLOGIA . Num. 1. Vol. 62. pp. 6-12. 2016. Científic.

• Gray matter atrophy is associated with funcional connectivity reorganization during the Pasat Auditory Serial Addition Test (PASAT) execution in Multiple Sclerosis (MS)

  Sabina Anna. Baltruschat, Noelia Ventura Campos, Alvaro Javier. Cruz-Gómez, Antonio Belenguer Benavides, Cristina Forn Frias. JOURNAL OF NEURORADIOLOGY. Num. 3. Vol. 42. pp. 141-149. 2015. Científic.

• Long-term effectiveness of glatiramer acetate in clinical practice conditions

  Carmen Arnal García, María del Campo Amigo Jorrín, Carme Lema Devesa, Noemí Llopis, R. Sánchez de la Rosa, XPERIENCIA-5 Study Group, Antonio Belenguer Benavides. JOURNAL OF CLINICAL NEUROSCIENCE . Num. 12. Vol. 21. pp. 2212-2218. 2014. Científic.

• Pseudoictus en el código ictus. Frecuencia, diagnóstico, tratamiento y destino

  Geffner Sclarsky, A Simón Gonzálbo, C. Soriano Soriano, C. Vilar Fabra, Berta Claramonte Clausell, Antonio Belenguer Benavides. EMERGENCIAS. Num. 6. Vol. 26. pp. 437-442. 2014. Científic.

• Regional brain atrophy and functional connectivity changes related to fatigue in multiple sclerosis

  Álvaro Javier Cruz Gómez, Noelia Ventura Campos, Antonio Belenguer Benavides, César Carlos Ávila Rivera, Cristina Forn Frías. PLOS ONE. Num. 10. Vol. 8. pp. 1-8. 2013. Científic.

• Task-load manipulation in the Symbol Digit Modalities Test: An alternative measure of information processing speed

  Cristina Forn Frías, P. Ripollés, A.J. Cruz Gómez, Antonio Belenguer Benavides, J.A. González Torre, César Carlos Ávila Rivera. BRAIN AND COGNITION. Num. 2. Vol. 82. pp. 152-160. 2013. Científic.

• Evaluación de la calidad de vida mediante cuestionario PRIMUS en población española de pacientes con esclerosis múltiple

  M.A. Hernández, S. Mora, Grupo Trabajo Estudio SLIMS, Antonio Belenguer Benavides. NEUROLOGIA . Num. 6. Vol. 28. pp. 340-347. 2013. Científic.

• Patterns of care and outcome for patients with gliobastoma diagnosed during 2008-2010 in Spain

  Francesc Graus, Jordi Bruna, Javier Pardo, Domingo Escudero, Dolores Vilas, Inés Barceló, Marta Brell, Carmen Pascual, José A. Crespo, Elena Erro, Juan C. García Romero, Jordi Estela, Juan Martino, Almudena García Castaño, Elena Mata, Manuela Lema, Miguel Gelabert, Rafel Fuentes, Pedro Pérez, Arancha Manzano, Jesús Aguas, Antonio Belenguer Benavides, ...... ......, Eugenia Verger. NEURO-ONCOLOGY . Num. 6. Vol. 15. pp. 797-805. 2013. Científic.